Literature DB >> 30191025

Role of alcohol in the development and progression of hepatocellular carcinoma.

Iain H McKillop1,1, Laura W Schrum2,2, Kyle J Thompson1,1.   

Abstract

Hepatocellular carcinoma (HCC) is a significant cause of cancer-related morbidity and mortality. Chronic, heavy ethanol consumption is a major risk for developing the worsening liver pathologies that culminate in hepatic cirrhosis, the leading risk factor for developing HCC. A significant body of work reports the biochemical and pathological consequences of ethanol consumption and metabolism during hepatocarcinogeneis. The systemic effects of ethanol means organ system interactions are equally important in understanding the initiation and progression of HCC within the alcoholic liver. This review aims to summarize the effects of ethanol-ethanol metabolism during the pathogenesis of alcoholic liver disease, the progression toward HCC and the importance of ethanol as a comorbid factor for HCC development.

Entities:  

Keywords:  DNA adducts; Sirtuin-1 (Sirt-1); alcohol; hepatocellular carcinoma (HCC); reactive oxygen species (ROS)

Year:  2015        PMID: 30191025      PMCID: PMC6095421          DOI: 10.2217/hep.15.40

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  152 in total

1.  Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase.

Authors:  Carl M Oneta; Charles S Lieber; JunJie Li; Sigmund Rüttimann; Beat Schmid; Jürg Lattmann; Alan S Rosman; Helmut K Seitz
Journal:  J Hepatol       Date:  2002-01       Impact factor: 25.083

Review 2.  The P450 catalytic cycle and oxygenation mechanism.

Authors:  D F Lewis; J M Pratt
Journal:  Drug Metab Rev       Date:  1998-11       Impact factor: 4.518

3.  New human liver alcohol dehydrogenase forms with unique kinetic characteristics.

Authors:  X Parés; B L Vallee
Journal:  Biochem Biophys Res Commun       Date:  1981-01-15       Impact factor: 3.575

4.  Ethanol promotes intestinal tumorigenesis in the MIN mouse. Multiple intestinal neoplasia.

Authors:  Hemant K Roy; James M Gulizia; William J Karolski; Anne Ratashak; Michael F Sorrell; Dean Tuma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-11       Impact factor: 4.254

5.  Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease.

Authors:  O Niemelä; S Parkkila; S Ylä-Herttuala; J Villanueva; B Ruebner; C H Halsted
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

6.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.

Authors:  Masahiro Munaka; Kiyotaka Kohshi; Toshihiro Kawamoto; Shin Takasawa; Naoki Nagata; Hideaki Itoh; Susumu Oda; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

7.  A meta-analysis of alcohol consumption and the risk of 15 diseases.

Authors:  Giovanni Corrao; Vincenzo Bagnardi; Antonella Zambon; Carlo La Vecchia
Journal:  Prev Med       Date:  2004-05       Impact factor: 4.018

8.  Resveratrol alleviates alcoholic fatty liver in mice.

Authors:  Joanne M Ajmo; Xiaomei Liang; Christopher Q Rogers; Brandi Pennock; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

Review 9.  Folate, alcohol, and liver disease.

Authors:  Valentina Medici; Charles H Halsted
Journal:  Mol Nutr Food Res       Date:  2012-11-08       Impact factor: 5.914

10.  Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.

Authors:  Fei Wang; Jin-Lian Yang; Ke-ke Yu; Mei Xu; You-zhi Xu; Li Chen; Yan-min Lu; Hao-shu Fang; Xin-yi Wang; Zhong-qian Hu; Fei-fei Li; Lixin Kan; Jia Luo; Si-Ying Wang
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

View more
  6 in total

Review 1.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

2.  Use of a crossed high alcohol preferring (cHAP) mouse model with the NIAAA-model of chronic-binge ethanol intake to study liver injury.

Authors:  Kyle J Thompson; Shayan S Nazari; W Carl Jacobs; Nicholas J Grahame; Iain H McKillop
Journal:  Alcohol Alcohol       Date:  2017-11-01       Impact factor: 2.826

Review 3.  Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma.

Authors:  Juncheng Wei; Deyu Fang
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

4.  Association Between Changes in Alcohol Consumption and Cancer Risk.

Authors:  Jung Eun Yoo; Kyungdo Han; Dong Wook Shin; Dahye Kim; Bong-Seong Kim; Sohyun Chun; Keun Hye Jeon; Wonyoung Jung; Jinsung Park; Jin Ho Park; Kui Son Choi; Joo Sung Kim
Journal:  JAMA Netw Open       Date:  2022-08-01

5.  Chronic Alcohol Exposure of Cells Using Controlled Alcohol-Releasing Capillaries.

Authors:  Wanil Kim; Hye-Seon Jeong; Sang-Chan Kim; Chang-Hyung Choi; Kyung-Ha Lee
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

Review 6.  Protective Mechanism of Edible Food Plants against Alcoholic Liver Disease with Special Mention to Polyphenolic Compounds.

Authors:  Liang Zhao; Arshad Mehmood; Dongdong Yuan; Muhammad Usman; Mian Anjum Murtaza; Sanabil Yaqoob; Chengtao Wang
Journal:  Nutrients       Date:  2021-05-11       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.